Evidence map›Paper›PMID 41659858›Full record

ReviewFrontiers in immunology2026

Expanding the clinical spectrum of interleukin-2 receptor alpha chain deficiency: two novel cases with long-term hematopoietic stem cell transplantation outcome and literature review.

Maha Alzubedy, Ahmed Sayed Osman, Huda Alajlan, Anas M Alazami, Hamoud Al-Mousa

Abstract readCase ReportsReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maha AlzubedySection of Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Ahmed Sayed OsmanDepartment of Hematology Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Huda AlajlanDepartment of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Anas M AlazamiDepartment of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Hamoud Al-MousaSection of Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Interleukin-2 receptor alpha chain (IL2RA, CD25) deficiency is a rare autosomal recessive inborn error of immunity characterized by profound immune dysregulation, susceptibility to infections, and autoimmunity. Only 13 cases of Methods: The clinical course, laboratory findings, genetic diagnosis, and transplant outcomes of two patients managed at King Faisal Specialist Hospital & Research Centre were retrospectively reviewed. A comprehensive literature review was conducted to contextualize these cases. Results: Both patients presented with severe enteropathy, eczema, recurrent respiratory infections, growth failure, and features of allergic disease in early childhood. Immunological evaluation revealed hypergammaglobulinemia, impaired T-cell proliferation, reduced CD19 Discussion: The two cases expand the mutational and clinical spectrum of

Indexed as

Hematopoietic Stem Cell TransplantationImmunologic Deficiency SyndromesInterleukin-2 Receptor alpha SubunitFrameshift MutationGraft vs Host DiseaseHumansSiblingsTreatment OutcomeIL2RA protein, humanInterleukin-2 Receptor alpha SubunitautoimmunityCD25hematopoietic stem cell transplantationIL2RAimmune dysregulationimmunodeficiencyIPEXregulatory T cells

Identifiers

PMID41659858
PMCPMC12876145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.